Certified by Founder Lodge
Athernal Bio

START UP
1 Disclosed Funding Rounds $4,718,630
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.
Date | Round | Raised | Participating Investors |
---|---|---|---|
October, 02 ,2025 | Unknown | $4,718,630 |